Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Clinical trial NCT00633750 · COMPLETED
Trial details
- NCT number
- NCT00633750
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-08-01
- Primary completion
- 2007-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.